Is Rein Therapeutics RNTX stock testing important levels Q4 2025 Profit Disappoints ConocoPhillips COP Sector Consolidation Catalyst as Shells 136B ARC Resources Acquisition Signals Upstream Value Upside NCVA Virtus releases quarterly preferred share results with no unexpected shifts to planned cumulative distribution payouts